<DOC>
	<DOC>NCT01269905</DOC>
	<brief_summary>The optimal valve substitute for patients between 60-70 years is controversial. We compared anticoagulation-related adverse events (ARAE) in patients receiving mechanical heart valve replacement (MHVR) on INR self-management vs. stentless bioprosthesis, to assess whether the risk of structural valve deterioration (SVD) is still out-weighted by the benefit of not requiring permanent anticoagulation.</brief_summary>
	<brief_title>Choice of Valve Substitute in the Era of Oral Anticoagulation Self-Management</brief_title>
	<detailed_description />
	<criteria>heart valve replacement CABG Afib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2005</verification_date>
</DOC>